Results 101 to 110 of about 202,254 (242)
Refractory diffuse large B-cell Lymphoma
Journal of Taibah University Medical Sciences, 2023 Hajar Masrour, Latifa Lerhrib, Sanaa Bouchnafati, Widad Rhandour, Mounia Bouzayd, Laila Abarkan, Anas Oudrhiri, Nabil Al Saddiq, Rim Hanini, Yassine Chekkori, Falah Eddine Tohir, Ouazzani, Naoual Oubelkacem, Noufissa Alami Drideb, Zineb Khammar, Rhizlane Berrady +15 moredoaj +1 more sourcePan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma
Haematologica, 2017 Activation of the phosphatidylinositol 3-kinase/mechanistic target of rapamycin pathway plays a role in the pathogenesis of non-Hodgkin lymphoma. This multicenter, open-label phase 2 study evaluated buparlisib (BKM120), a pan-class I phosphatidylinositol Anas Younes, Gilles Salles, Giovanni Martinelli, Robert Gregory Bociek, Dolores Caballero Barrigon, Eva González Barca, Mehmet Turgut, John Gerecitano, Oliver Kong, Chaitali Babanrao Pisal, Ranjana Tavorath, Won Seog Kim +11 moredoaj +1 more sourceClinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era
, 2022 Yi Chen, Luting Luo, Lushan Chen, Xiaoyun Zheng, Xiaozhu Yang, Zhi‐Hong Zheng, Jing Zheng, Tingbo Liu, Ting Yang, Jianda Hu +9 moreopenalex +2 more sourcesPixantrone is a Safe and Effective Therapeutic Option for Elderly Patients with Relapsed Refractory Diffuse Large B-Cell Lymphoma in the Real-World Setting [PDF]
, 2022 E Verrou, Aggeliki Sevastoudi, Nikolaos Karampatzakis, T Triantafyllou, D Dalampira, Stavros Gogolopoulos, Laskarina Katsika, M Kamargianni, Gkogkos DA, Laoutidis ER, P. Koutoukoglou, Thaleia Papadopoulou, E Katodritou +12 moreopenalex +1 more sourceAdditional file 1 of Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy
, 2022 Miaomiao Li, Lan Mi, Chunyang Wang, Xiaojuan Wang, Jianhua Zhu, Fei Qi, Hui Yu, Yingying Ye, Dedao Wang, Jiaowu Cao, Dingyao Hu, Quanyu Yang, Dandan Zhao, Tonghui Ma, Yuqin Song, Jun Zhu +15 moreopenalex +1 more sourcePathophysiology and molecular aspects of diffuse large B-cell lymphoma
Revista Brasileira de Hematologia e Hemoterapia, 2012 Diffuse large B-Cell lymphoma is the most common subtype of non-Hodgkin lymphoma in the West. In Brazil, it is the fifth cause of cancer, with more than 55,000 cases and 26,000 deaths per year.Gisele Rodrigues Gouveia, Sheila Aparecida Coelho Siqueira, Juliana Pereira +2 moredoaj Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas [PDF]
, 2007 Integrative genomic and gene-expression analyses have identified amplified oncogenes in B-cell non-Hodgkin lymphoma (B-NHL), but the capability of such technologies to localize tumor suppressor genes within homozygous deletions remains unexplored.Agirre-Ena, X. (Xabier), Beltran, E. (E.), Climent, J. (J.), Dyer, M.J.S. (Martin J. S.), Fresquet, V. (Vicente), Garcia, J.F. (José Francisco), Karran, E.L. (E. L.), Marin, M. (Miguel), Martinez-Climent, J.A. (José Ángel), Marugan, I. (Isabel), Mestre-Escorihuela, C. (Cinta), Pinkel, D. (Daniel), Prosper, F. (Felipe), Richter, J.A. (José Ángel), Rosenwald, A. (Andreas), Rubio-Moscardo, F. (Fanny), Sanchez, L. (Lydia), Siebert, R. (Reiner), Staudt, L.M. (Louis M.), Sugimoto, K.J. (Kei-Ji), Wheat, L.M. (Luise M.) +20 morecore FEASIBILITY AND SAFETY OF HIGH‐DOSE METHOTREXATE INTERCALATED WITH R‐CHOP IN DIFFUSE LARGE B‐CELL LYMPHOMA: A SINGLE‐CENTER EXPERIENCE [PDF]
, 2023 Nicolò Rampi, Ramona Cassin, Cecilia Anna Fidanza, Nicola Cecchi, S. Stella, Luca Fedrizzi, Dario Consonni, Valentina Bellani, Francesca Cavallaro, Francesca Gaia Rossi +9 moreopenalex +1 more source
